Medical-grade wearable monitoring for every general ward bed — validated vital signs, automated early warning, one bracelet from admission to home.
Corsano combines a certified wrist-worn sensor, a secure cloud back end and clinician-facing dashboards into a single monitoring pathway. Nurses see trends instead of snapshots; researchers receive granular, IP-free signals; IT teams integrate through documented APIs.
Corsano’s installed base is the basis of our experience: every number below comes from devices in active hospital, home-monitoring or trial use.
In most general wards, vital signs are recorded a few times per day. Deterioration that starts between observations can remain invisible for hours. Continuous monitoring turns those blind spots into measurable trends.
Monitor every bed with one wearable instead of cabled spot-check devices, and push measurements straight into the electronic medical record.
Patients keep the same bracelet after discharge, so hospital-at-home and post-discharge pathways continue without re-onboarding or data gaps.
Continuous inputs feed automated early warning scores and predictive risk models, giving nursing staff objective escalation triggers.
Within the DETECT consortium, Corsano works with academic cardiology centres on wearable-based recognition of out-of-hospital cardiac arrest and automated alerting.
A multi-sensor wrist device engineered around patient comfort: light, discreet, single-purpose and simple enough for bedside handover in seconds.
Review the full list of measured and derived parameters, then connect them to your dashboards, EMR or third-party monitoring application.
Sponsors, CROs and academic groups use Corsano when consumer wearables cannot meet regulatory expectations. Certified hardware plus unrestricted raw data shortens the distance between signal collection and validated digital endpoints.
Create studies, define parameters and sampling frequency, follow compliance metrics and export datasets — all from one research portal.
Pharmaceutical teams build proprietary endpoints on top of IP-free raw signals in areas such as hypertension, immune oncology, frailty and sepsis.
Combine objective sensor data with electronic clinical outcome assessments so subjective reports and physiology can be analysed together.
Regulatory status determines whether wearable data can be used in care pathways and regulated studies. Corsano is audited as a medical device manufacturer, and our notified-body certification is verifiable.
I’ve tried out more wearable sensors than most people, and the CW287-2B is by far my favorite and most valuable. Congratulations to your entire team for your vision and for delivering on that. I believe your technology will have a significant impact on improving health across the globe.
As part of the DETECT consortium, our collaboration with Corsano has been instrumental in advancing technological solutions aimed at the early detection of cardiac arrest. This partnership is paving the way for significant breakthroughs that we believe will greatly enhance patient care and outcomes.
CardioWatch offers automated vital signs monitoring and integrates data into health records, easing our nursing staff’s workload. Our hospital effectively addressed implementation areas like data security and legalities. We’re very pleased with our Corsano partnership.
Clinical teams in the UK, France and Belgium describe how continuous monitoring changed their ward routines, escalation behaviour and nursing workload.
Cooperation is a core company value. Corsano designs and manufactures certified wearables and connects them to partner platforms through APIs and SDKs, so hospitals, CROs and industry teams can deliver their own services on top of our data.
Corsano joins consortia where continuous, high-resolution vital-sign data is a prerequisite. CardioWatch is used both for raw-signal acquisition up to 128 Hz and for validation trials of new algorithms.
We co-develop features and endpoints with consortium partners to strengthen applications and shorten the path from concept to clinical validation.
Browse publications & white papers
An energetically autonomous monitoring module that harvests energy from ambient light through a dedicated power-management microchip, combined with Narrow-Band IoT connectivity for ubiquitous data transfer.
Clinical validation of a comprehensive care solution enabling 24/7 monitoring of cardio-respiratory function in patients at risk of cardiovascular events, with Oslo University Hospital and University of Gothenburg.
Research toward faster recognition of cardiac arrest and resuscitation assistance, developed with Radboud UMC, Erasmus MC and Amsterdam UMC using CardioWatch 287 to trigger emergency alerting.
A new distribution agreement brings the Corsano multi-parameter wearable to acute care and monitoring customers in the United States.
Read more
A strategic partnership to deploy continuous wearable monitoring across general wards within the Netcare hospital network.
Read more
Medtronic extends its acute care and monitoring portfolio in Europe with Corsano’s certified wearable monitoring platform.
Read moreThe CardioWatch 287 platform derives up to 19 vital parameters, including heart rate, heart rate variability, respiration rate, SpO2, skin temperature, activity and posture, sleep staging and single-lead ECG rhythm strips. Because sampling is continuous rather than episodic, clinicians see the trajectory between nursing rounds instead of isolated spot-check values.
Corsano is a regulated medical device manufacturer. The CardioWatch platform is CE-MDR certified and FDA 510(k) cleared, developed under ISO 13485 quality management, with clinically validated vital-sign algorithms. Feature availability may vary by country or region and is subject to applicable regulatory approvals and clearances.
Yes. Corsano provides IP-free access to raw accelerometer, PPG (green, red, infrared), ECG, temperature and GSR signals at up to 128 Hz. Research groups and pharmaceutical sponsors use this granular data to build and validate their own digital biomarkers and AI/ML models, without being restricted to vendor-derived features.
Measured parameters and automated early warning scores are delivered through documented REST APIs, while mobile SDKs allow third-party applications to pair and sync directly with the bracelet. This makes it possible to surface Corsano data inside electronic medical records, nurse-call systems or partner monitoring platforms without changing clinical workflows.
Most hospitals start with one ward or one care pathway, validating alarm thresholds, escalation protocols and nursing workflow. After the pilot, deployment typically expands ward by ward, followed by post-discharge continuation using the same device. Corsano supports data-protection review, integration work and clinical training throughout.
The platform is built on best-practice security with GDPR and HIPAA-aligned processes, role-based access control and documented data-processing agreements. Study and hospital administrators control which parameters are collected, at what frequency and who may export them.
Speak with our clinical and technical specialists about parameters, integration requirements, regulatory availability in your region and pilot design.
Contact Corsano HealthFeature availability may vary by country or region and is subject to applicable regulatory approvals, clearances, and local regulatory requirements.
